Arbor Biotechnologies
Arbor Biotechnologies™ - Home
Cambridge, United States · Founded 2016 · $304.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- arbor.bio
- Total Funding
- $304.5M
- Last Round
- $73.9M Series CMar 2025
- Rounds
- 3
About
Arbor Biotechnologies is a next-generation gene editing company based in Cambridge, MA, advancing a pipeline of novel genomic medicines for patients with genetic diseases. The company discovers and develops programmable DNA editors — building on CRISPR with advanced proprietary tools — to enable curative outcomes across liver, CNS, and other disease areas. Arbor partners with global pharmaceutical leaders to bring its editing platform to clinical-stage programs.
Summary
Arbor Biotechnologies is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $304.5M in total across 3 rounds, most recently a $73.9M Series C round in Mar 2025. Investors include ARCH Venture Partners, TCGX and ArrowMark Partners.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2025
Sign up to see all 3 rounds
Series A through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/arbor-biotechnologies"><img src="https://indexed.vc/api/badge/company/arbor-biotechnologies" alt="Arbor Biotechnologies on Indexed.vc" width="260" height="76" /></a>